MRI Study of the Gastric Insufflation After High-flow Nasal Oxygen (HFNO)
Sponsor
University of Liege (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04735276
Collaborator
(none)
30
5
Study Details
Study Description
Brief Summary
HFNO CAN BE USED AS A PREOXYGENATION TECHNIQUE BUT IS IT A SAFE TECHNIQUE IN TERMS OF GASTRIC INSUFFLATION?
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The objective of this study is to evaluate by MRI whether the stomach is insufflated during HFNO use in healthy volunteers.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
MRI Study of the Gastric Insufflation After High-flow Nasal Oxygen (HFNO)
Anticipated Study Start Date
:
Apr 1, 2021
Anticipated Primary Completion Date
:
May 30, 2021
Anticipated Study Completion Date
:
Aug 30, 2021
Outcome Measures
Primary Outcome Measures
- Measurement of the antero-posterior and cranio-caudal diameters of the gastric antrum [through study completion, an average of 1 year]
surface of the gastric antrum
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Adults Volunteers
Exclusion Criteria:
-
Pregnancy
-
Claustrophobia
-
Gastric surgery
-
Gastric pathology
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Liege
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Benjamin Javillier,
Principal Investigator,
University of Liege
ClinicalTrials.gov Identifier:
NCT04735276
Other Study ID Numbers:
- Optirm
First Posted:
Feb 3, 2021
Last Update Posted:
Feb 3, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No